Israel Englander Keros Therapeutics, Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 53,346 shares of KROS stock, worth $920,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,346

Previous 13,705 289.24%

Holding current value

$920,751

Previous $182,000 363.19%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$13.34 - $16.05 $528,810 - $636,238	39,641 Added 289.24%	53,346 $843,000
Q2 2025 Aug 14, 2025	SELL	$9.55 - $15.11 $2.1 Million - $3.32 Million	-219,498 Reduced 94.12%	13,705 $182,000
Q1 2025 May 15, 2025	SELL	$10.15 - $16.1 $6.55 Million - $10.4 Million	-644,956 Reduced 73.44%	233,203 $2.38 Million
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $4.77 Million - $21.4 Million	305,169 Added 53.26%	878,159 $13.9 Million
Q3 2024 Nov 14, 2024	BUY	$41.68 - $58.07 $7.5 Million - $10.5 Million	180,034 Added 45.82%	572,990 $33.3 Million

Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $2.46 Million - $3.7 Million	55,293 Added 16.38%	392,956 $18 Million
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $7.61 Million - $13 Million	-184,465 Reduced 35.33%	337,663 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $13.1 Million - $19.8 Million	482,232 Added 1208.72%	522,128 $20.8 Million
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $578,386 - $791,828	15,523 Added 63.69%	39,896 $1.6 Million
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $6.5 Million - $9.31 Million	-156,904 Reduced 86.55%	24,373 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$39.45 - $51.77 $7.15 Million - $9.38 Million	181,277 New	181,277 $8.71 Million
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $1.71 Million - $4.4 Million	-65,688 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $545,201 - $768,355	12,944 Added 24.54%	65,688 $3.57 Million
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $4.77 Million - $8.12 Million	-129,132 Reduced 71.0%	52,744 $3.09 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $1.9 Million - $2.84 Million	64,961 Added 55.56%	181,876 $7.2 Million
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $566,040 - $935,968	-13,350 Reduced 10.25%	116,915 $4.97 Million
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $2.28 Million - $3.19 Million	42,309 Added 48.1%	130,265 $8.02 Million
Q4 2020 Feb 16, 2021	BUY	$36.0 - $82.74 $2.85 Million - $6.55 Million	79,217 Added 906.48%	87,956 $6.2 Million
Q3 2020 Nov 16, 2020	BUY	$27.04 - $62.21 $236,302 - $543,653	8,739 New	8,739 $337,000

Others Institutions Holding KROS

# of Institutions

169

Shares Held

35.4M

Call Options Held

574K

Put Options Held

325K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account